NasdaqGM - Nasdaq Real Time Price
USD
CRISPR Therapeutics AG (CRSP)
54.76
+0.65
(+1.19%)
As of 10:54:31 AM EDT. Market Open.
Trade CRSP on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutCRISPR Therapeutics appointed internal finance executive Andrew J. Silver as chief financial officer after Raju Prasad resigned. Coverage centers on whether Silver can control cash use while advancing CTX310, zugo-cel, and other pipeline programs. CRISPR Therapeutics is also approaching Phase 1b CTX310 data expected in early November. CRSP is up 2.24% in the current regular sessionas of October 29, 2026.
